繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 免疫系统 >> 器官移植 >> 常用免疫抑制剂及用药指南 >> Nulojix(贝拉西普注射液)

Nulojix(贝拉西普注射液)

2012-11-22 22:29:10  作者:新特药房  来源:互联网  浏览次数:173  文字大小:【】【】【
简介: 近日,美国食品和药物管理局(FDA)宣布,临床医生在处方一种肾移植的药物belatacept(Nulojix,施贵宝公司)时,必须牢记2个潜在的致命性并发症,该药物6月15日被批准时已知这2个并发症。 这2个可能的 ...

FDA药品评价和研究中的抗微生物产品室主任Edward Cox, M.D., M.P.H,说“Nulojix为肾移植患者提供一种新选择,”“这个新药与其它免疫抑制剂联用有助于在接受肾移植患者中控制免疫系统和预防器官排斥.”
批准日期:2011年6月15日:公司:百时美施贵宝[Bristol-Myers Squibb]公司
NULOJIX(belatacept)为静脉注射使用


NULOJIX Rx
Generic Name and Formulations:
Belatacept 250mg/vial; lyophilized pwd for IV infusion after reconstitution.

Company:
Bristol-Myers Squibb
Indications for NULOJIX:
Organ rejection prophylaxis in patients receiving a kidney transplant, in combination with basiliximab induction, mycophenolate mofetil, and corticosteroids. Limitations of use: use only in patients who are EBV seropositive. Use has not been established for prophylaxis of organ rejection in transplanted organs other than kidney.

Adult Dose for NULOJIX:
See full labeling. Administering higher than the recommended doses or more frequent dosing: not recommended. Base total infusion dose on patient's body wt. at the time of transplantation. The prescribed dose must be evenly divisible by 12.5mg for accurate reconstitution. Give as IV infusion over 30 mins. Initial phase (Day 1 [day of transplantation, prior to implantation]; Day 5 [approx. 96 hours after Day 1 dose]; end of Weeks 2, 4, 8, 12 after transplantation): 10mg/kg. Maintenance phase (end of Week 16 after transplantation and every 4 weeks±3 days) thereafter: 5mg/kg.

Children's Dose for NULOJIX:
<18yrs: not established.

Pharmacological Class:
Selective T-cell costimulation blocker.

Rems:
YES

Contraindications:
Transplant recipients who are Epstein-Barr virus (EBV) seronegative or with unknown EBV serostatus.

Warnings/Precautions:
Liver transplant patients: not recommended. Increased risk of post-transplant lymphoproliferative disorder (PTLD) or progressive multifocal leukoencephalopathy (PML); monitor for new or worsening neurological, cognitive, or behavioral signs/symptoms. Increased risk of malignancies (including the skin); limit sun and UV exposure. Increased risk of bacterial, viral (eg, CMV, herpes), fungal, protozoal, and opportunistic infections. Evaluate and treat latent TB infection prior to initiating therapy. Prophylaxis for CMV or pneumocystis after transplantation. Monitor for polyoma virus nephropathy (PVAN). Acute rejection and graft loss with corticosteroid minimization: utilization should be consistent with clinical trial experience (see full labeling). Pregnancy (Cat.C). Nursing mothers.

Interactions:
Concomitant live vaccines: not recommended. Potentially can alter CYP450 substrates. Concomitant mycophenolate mofetil: may possibly affect mycophenolic acid exposure after crossover to/from cyclosporine.

Adverse Reactions:
Anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia; PTLD (predominately CNS), PML, PVAN, other malignancies.

How Supplied:
Single-use vial—1

责任编辑:admin


相关文章
Nulojix(贝拉西普注射液,Belatacept)
 

最新文章

更多

· Nulojix(贝拉西普注射液)
· 抗人T细胞猪免疫球蛋白
· 依维莫司片|Zortress(Ev...
· 美复醒(注射用吗替麦考...
· 扶异(吗替麦考酚酯胶囊)
· 扶异(注射用吗替麦考酚酯)
· 匹多莫德分散片(Pidoti...
· 贝拉西普冻干粉静脉注射...
· 依维莫司片剂|Afinitor(...
· 新普乐可复(他克莫司缓释...

推荐文章

更多

· Nulojix(贝拉西普注射液)
· 抗人T细胞猪免疫球蛋白
· 依维莫司片|Zortress(Ev...
· 美复醒(注射用吗替麦考...
· 扶异(吗替麦考酚酯胶囊)
· 扶异(注射用吗替麦考酚酯)
· 匹多莫德分散片(Pidoti...
· 贝拉西普冻干粉静脉注射...
· 依维莫司片剂|Afinitor(...
· 新普乐可复(他克莫司缓释...

热点文章

更多